Trevena Inc (TRVN)
4.605
+0.61
(+15.19%)
USD |
NASDAQ |
Oct 04, 16:00
2.45
-2.16
(-46.80%)
After-Hours: 20:00
Trevena Shareholders Equity (Annual): -7.657M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -7.657M |
| December 31, 2022 | 15.60M |
| December 31, 2021 | 64.63M |
| December 31, 2020 | 104.07M |
| December 31, 2019 | 30.08M |
| December 31, 2018 | 41.53M |
| December 31, 2017 | 34.63M |
| Date | Value |
|---|---|
| December 31, 2016 | 78.58M |
| December 31, 2015 | 143.13M |
| December 31, 2014 | 99.20M |
| December 31, 2013 | 38.99M |
| December 31, 2012 | -0.0392M |
| December 31, 2011 | 15.42M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-7.657M
Minimum
2023
104.07M
Maximum
2020
41.34M
Average
30.08M
Median
2019
Shareholders Equity (Annual) Benchmarks
| Syndax Pharmaceuticals Inc | 554.20M |
| Arcus Biosciences Inc | 462.00M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |